Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage

Key Points Newly acquired NANGS are significantly reduced in advanced-stage but not in early-stage t(14;18)-negative FL. IGHV4-34 usage in combination with newly acquired NANGS in FR3 are significantly associated with t(14;18)-negative FL.